Identifying symptomatic and neuroprotective strategies for cereballar ataxia
Identifying symptomatic and neuroprotective strategies for cereballar ataxia
批准号:
10408869
负责人:
Vikram Govindaraju Shakkottai
金额:
$50.74万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-20 至 2024-03-31
关键词:
AddressAtaxiaBacterial Artificial ChromosomesBiologyBrainBrain StemCause of DeathCell physiologyCerebellar AtaxiaCerebellumCessation of lifeDataDiseaseElectrophysiology (science)EventFunctional disorderFundingGenesGenetic TranscriptionGenetic studyGlutamineImmunoprecipitationImpairmentInferiorIon ChannelKnock-inKnock-in MouseLY6E geneLeadLinkMJD1 proteinMediatingMembraneModelingMolecularMotorNerve DegenerationNeuronal DysfunctionNeuronsOlives - dietaryPathogenesisPathogenicityPathway interactionsPhysiologyPlayPotassiumPotassium ChannelProteinsPublicationsPurkinje CellsRNARNA StabilityRoleSeriesSliceSpinocerebellar AtaxiasTranscriptTransgenic MiceTransgenic ModelTransgenic OrganismsViralWorkchromatin immunoprecipitationimprovedin vivoinsightmotor disordermouse geneticsmouse modelmutantneuron losspolyglutamineprematuretargeted treatmenttherapeutic targettranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A remarkable feature of the neurodegenerative spinocerebellar ataxias (SCAs) is that glutamine
encoding CAG (polyQ) expansions in a diverse set of genes all cause Purkinje cell (PC) and brainstem neuron
degeneration. This fact suggests that these genetically distinct polyQ SCAs share key upstream pathogenic
events. While PC dysfunction may principally drive motor dysfunction in polyQ SCAs, brainstem dysfunction
more closely correlates with premature death. This proposal explores unifying molecular events causing
neuronal dysfunction and degeneration in ataxia, with a focus on the polyQ SCAs.
In a series of recent publications supported by new data, we identified alterations in potassium (K+)
channels as a key feature in several polyQ SCAs. Importantly, in SCA1 transgenic mice, we previously showed
that restoring K+ channel expression or function rescued membrane hyperexcitability, improved motor
dysfunction and reduced PC degeneration. It is now important to examine the links between K+ channel
dysregulation and altered membrane excitability in cerebellar and brainstem neurons, and the relationship of
these events to motor dysfunction and neurodegeneration in several polyQ SCAs.
In the prior funding period we identified K+ channel dysfunction as the basis of PC spiking abnormalities
in models of the polyQ ataxias SCA1, SCA2, SCA3 and SCA7, which together account for the majority of
SCAs. To explore shared links between neuronal dysfunction and these functionally diverse polyQ disease
proteins, we applied unbiased transcriptomics in models of SCA1, SCA2 and SCA7, and identified a common
theme, beginning early in disease: significant reduction in cerebellar transcripts for key ion channels important
for K+ channel function. Preliminary data also suggest a reduction in K+ channel transcripts in SCA1 medullary
brainstem neurons. The proposal seeks to determine whether altered K+ channel function tied to the biology of
diverse polyQ proteins in regulating the transcription and/or stability of ion channel transcripts is a unifying
mechanism underlying neuronal dysfunction and degeneration in polyQ SCAs through the following aims: Aim
1: Determine whether there is shared potassium channel dysfunction in cerebellar Purkinje cells and brainstem
neurons in SCA1. Aim 2: Determine whether shared Purkinje cell dysfunction is responsible for motor
dysfunction and neurodegeneration in SCA1, SCA2 and SCA7. Aim 3: Define the basis for shared reduction in
ion channel transcripts in SCA1, SCA2 and SCA7. We anticipate that successful completion of these studies
will definitively establish the important role of K+ channel dysfunction in the disease pathogenesis of a wide
variety of polyQ ataxias. Further, these studies will demonstrate that abnormal Purkinje neuron spiking causes
motor dysfunction in SCAs Lastly, the proposed work will also answer whether K+ channels are compelling
therapeutic targets to counter cerebellar and brainstem dysfunction in cerebellar ataxia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying symptomatic and neuroprotective strategies for cereballar ataxia
-
批准号:10605349
-
项目类别:
-
资助金额:$50.29万
-
财政年份:2021
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Identifying symptomatic and neuroprotective strategies for cereballar ataxia
-
批准号:10394772
-
项目类别:
-
资助金额:$50.68万
-
财政年份:2021
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Identifying symptomatic and neuroprotective strategies for cerebellar ataxia
-
批准号:8875790
-
项目类别:
-
资助金额:$37.27万
-
财政年份:2013
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Identifying symptomatic and neuroprotective strategies for cerebellar ataxia
-
批准号:9913591
-
项目类别:
-
资助金额:$48.32万
-
财政年份:2013
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Identifying symptomatic and neuroprotective strategies for cerebellar ataxia
-
批准号:9276147
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2013
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Identifying symptomatic and neuroprotective strategies for cerebellar ataxia
-
批准号:8610842
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2013
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Identifying symptomatic and neuroprotective strategies for cerebellar ataxia
-
批准号:8739327
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2013
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Targeting physiologic changes as a route towards therapy for degenerative ataxias
-
批准号:8541898
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2010
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Targeting physiologic changes as a route towards therapy for degenerative ataxias
-
批准号:8026977
-
项目类别:
-
资助金额:$16.97万
-
财政年份:2010
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Targeting physiologic changes as a route towards therapy for degenerative ataxias
-
批准号:8306263
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2010
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Targeting physiologic changes as a route towards therapy for degenerative ataxias
-
批准号:8706243
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2010
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
Targeting physiologic changes as a route towards therapy for degenerative ataxias
-
批准号:8131853
-
项目类别:
-
资助金额:$16.97万
-
财政年份:2010
-
负责人:Vikram Govindaraju Shakkottai
-
依托单位:
海外基金